查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1967289

非侵入式塑形設備市場：依產品類型、電源、技術類型、應用和最終用戶分類－2026-2032年全球預測

Non-Invasive Body Shaping Equipment Market by Product Type, Power Source, Technology Type, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

非侵入式塑形設備市場預計到 2025 年將達到 14.9 億美元，到 2026 年將成長到 16.7 億美元，到 2032 年將達到 33.8 億美元，年複合成長率為 12.41%。

主要市場統計數據
基準年 2025 14.9億美元
預計年份：2026年 16.7億美元
預測年份 2032 33.8億美元
複合年成長率 (%) 12.41%

本報告全面概​​述了非侵入性塑形技術的融合、不斷變化的臨床需求、監管趨勢以及對相關人員的實際影響。

由於技術日趨成熟、消費者期望不斷變化以及監管審查日益嚴格，非侵入式塑形設備市場正處於轉折點。臨床醫生和美容從業者越來越傾向於尋求兼具安全性、有效性和多功能性的平台，以確保在不同患者群體中都能獲得可預測的臨床效果。同時，設備設計者也更重視人體工學和使用者體驗，以縮短學習曲線，並提高高週轉率診所環境下的處理能力。這些趨勢與醫保報銷談判的日趨成熟以及對治療後數據以證明其價值的日益成長的需求同步發展。

分析近期關稅措施如何重塑設備相關人員的籌資策略、產品重新設計重點、分銷模式和總成本考量。

近期關稅措施的累積效應，為製造商和通路夥伴的採購、定價和供應鏈規劃帶來了新的策略複雜性。關稅帶來的成本壓力迫使採購部門重新評估其供應商組合，加速了關於近岸外包、本地組裝和垂直整合的討論，以確保利潤率和準時交付。對於依賴進口零件和成品的設備供應商而言，關稅迫使他們重新設計物料材料清單（BOM），轉而優先考慮國內可獲得的替代方案以及可從多個地區採購的標準化模組。

將產品類型、電源、技術模式、臨床應用和最終用戶特徵關聯起來的關鍵細分洞察揭示了策略市場路徑。

從精細的市場區隔觀點來看，該領域涵蓋了眾多影響策略決策和市場進入決策的技術、產品和客戶因素。從產品類型檢驗，市場包括聲波設備、冷凍消脂設備、雷射設備、射頻設備、超音波設備和真空輔助技術。雷射產品可進一步分為飛梭雷射飛梭雷射系統，而射頻解決方案則分為雙極射頻和單極射頻。這種產品多樣性導致了臨床價值提案的差異化，其中施用器的設計和能量調節決定了適應症的範圍和治療成本。

多方面的區域分析重點介紹了美洲、歐洲、中東、非洲和亞太地區如何塑造各自的採用模式、法規和商業模式。

區域趨勢持續對產品上市模式、監管時間表和通路結構產生重大影響。在美洲，需求受多種因素共同影響，包括消費者主導的美容趨勢、集中化的診所網路以及重視可靠臨床證據和強力的上市後監測的務實法規環境。該地區的相關人員通常優先考慮可擴展性、在高通量診所中的易操作性以及旨在加速多中心運營部署的綜合培訓計劃。

從分析的觀點決定企業績效和復甦的競爭、創新策略、夥伴關係模式和韌性來源。

該產業的競爭格局呈現出三者並存的特點：既有擁有成熟技術的成熟企業，也有靈活敏捷的專業供應商，還有越來越多獲得創業投資支持的新興參與企業。成熟企業通常依靠廣泛的分銷網路、完善的服務體系和豐富的臨床試驗經驗來維持市場佔有率。同時，小規模但極具創新精神的企業則憑藉特定的臨床優勢、簡化的監管路徑和快速迭代的研發週期展開競爭。醫療設備製造商與臨床研究中心之間的合作日益普遍，以此加速證據產生並檢驗新的適應症。

為製造商、經銷商和臨床營運商提供切實可行的策略建議，以加強供應鏈韌性、進行臨床檢驗並實現商業性差異化。

領導者應採取務實的多層次策略，將市場複雜性轉化為競爭優勢。首先，應優先考慮供應商多元化和模組化產品設計，以便在不影響臨床性能的前提下替換對關稅敏感的零件。這種方法可以降低單一供應商帶來的衝擊，並在政策變化時縮短向區域組裝或契約製造的過渡時間。同時，至關重要的是投資於產生嚴謹的臨床證據，並將醫療設備的性能與明確的患者報告結果指標和經濟價值提案聯繫起來。可靠的數據將加速產品應用，並有助於與監管機構的溝通。

本研究採用高度透明的混合調查方法，明確規定了資料來源（包括一手和二手資訊）、分析方法、檢驗通訊協定和情境測試。

本報告採用混合研究方法，結合一手訪談、二手文獻回顧和檢驗，確保分析的嚴謹性和研究結果的實用性。一手研究包括對臨床意見領袖、採購專家、監管顧問和通路合作夥伴進行結構化訪談，以了解實際應用中的限制和不斷變化的需求趨勢。二級資訊來源包括同行評審的臨床研究、監管指導文件、專利申請和上市公司披露資訊，這些資料被整合起來，用於分析技術趨勢和競爭格局。

總之，這項綜合分析提取了在不斷發展的塑形設備市場中保持永續競爭力所必需的策略性要求、營運權衡和長期優先事項。

總之，非侵入式塑形設備市場正從以單一治療方式為中心的提案轉向以實證醫學為導向的整合平台轉型，更加重視安全性、病患體驗和可衡量的療效。技術進步正在拓展適應症範圍並簡化臨床工作流程，而供應鏈中斷和關稅等政策措施則加速了採購和產品設計的策略轉變。那些投資於與明確臨床終點相符的研發、實現供應鏈多元化並建立以服務為中心的經營模式，將更有利於應對這些變化並實現永續成長。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 非侵入式塑形設備市場：依產品類型分類

  • 聲波裝置
  • 冷凍溶脂裝置
  • 雷射設備
    • 飛梭雷射系統
    • 非飛梭雷射系統
  • 高頻設備
    • 雙極射頻
    • 單極高頻
  • 超音波設備
  • 真空輔助技術

第9章 非侵入式塑形設備市場（依電源分類）

  • 電池驅動裝置
  • 帶電線的電器
  • 可充電無線設備

第10章 非侵入式塑形設備市場：依技術類型分類

  • 冷凍溶脂
  • 電磁肌肉刺激
  • 高強度聚焦超音波
  • 紅外線照光治療
  • 雷射減脂
  • 高頻
  • 真空吸力技術

第11章 非侵入式塑形設備市場：依應用領域分類

  • 減少橘皮組織
  • 減脂
  • 塑形
  • 肌肉塑形
  • 皮膚緊緻

第12章 非侵入式塑身設備市場：依最終用戶分類

  • 美容診所
  • 美容院
  • 醫院
  • 醫療水療中心

第13章 非侵入式塑形設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 非侵入式塑形設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 非侵入式塑形設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國非侵入式塑形設備市場

第17章：中國非侵入式塑形設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alma Lasers Ltd.
  • Asclepion Laser Technologies GmbH
  • BioSculpt Solutions, Inc.
  • Candela Medical, Inc.
  • Croma Aesthetics, Inc.
  • CRYO SCIENCE sp.z oo
  • Cutera, Inc.
  • Cynosure, Inc.
  • DEKA MELASrl by Elen Group
  • Endymed Medical Ltd.
  • Erchonia Corporation
  • Fotona doo
  • InMode Ltd.
  • Konmison
  • Lumenis Ltd.
  • Lutronic Corporation
  • RFHIC Corporation
  • Sciton, Inc.
  • Silhouette Aesthetics, LLC
  • Solta Medical, Inc. by Bausch Health
  • Venus Concept, Inc.
Product Code: MRR-4F7A6D4FF37A

The Non-Invasive Body Shaping Equipment Market was valued at USD 1.49 billion in 2025 and is projected to grow to USD 1.67 billion in 2026, with a CAGR of 12.41%, reaching USD 3.38 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.49 billion
Estimated Year [2026] USD 1.67 billion
Forecast Year [2032] USD 3.38 billion
CAGR (%) 12.41%

Comprehensive introduction framing technological convergence, clinical demand evolution, regulatory dynamics, and practical implications for non-invasive body shaping stakeholders

The non-invasive body shaping equipment landscape is at an inflection point driven by technological refinement, shifting consumer expectations, and heightened regulatory scrutiny. Clinicians and aesthetic operators are increasingly demanding platforms that combine safety, efficacy, and versatility while enabling predictable clinical outcomes across diverse patient cohorts. Concurrently, device designers are prioritizing ergonomics and user experience to shorten learning curves and improve throughput in high-turnover clinic settings. These trends are unfolding alongside a maturation of reimbursement discourse and elevated expectations for post-procedure data to demonstrate value.

Transitioning from a period primarily focused on single-modality offerings, the industry now emphasizes integrated solutions that can deliver multi-indication treatments with minimal downtime. This evolution is accelerating convergence between traditional cosmetic technology disciplines - optical, thermal, acoustic, and mechanical - and is prompting manufacturers to rethink modular architectures, software-driven treatment planning, and remote serviceability. Stakeholders who understand how clinical evidence, practitioner training, device interoperability, and patient satisfaction metrics interplay will be best positioned to capture demand and convert it into durable competitive advantage.

The sector has experienced transformative shifts that extend beyond device specifications to encompass supply chains, channel economics, and buyer expectations. Advances in energy delivery, coupled with optimized applicator design and integrated feedback systems, have improved treatment precision and reduced adverse events, leading to broader acceptance among clinicians and end consumers. At the same time, software-enabled protocols and digital patient tracking are elevating expectations for measurable outcomes and clinic-level performance metrics.

Concurrently, supply chain reconfiguration and rising raw material scrutiny have reshaped procurement strategies. Manufacturers are reassessing single-source dependencies and investing in component standardization to reduce lead-time variability. Regulatory pathways have also evolved, with authorities demanding more robust clinical datasets and clearer risk mitigation frameworks. These shifts have encouraged strategic partnerships between technology firms and clinical research networks, further accelerating commercialization timelines for validated therapies. Together, these changes are remapping competitive positions and creating new entry points for specialized, patient-centric offerings.

Analysis of how recent tariff measures have reshaped sourcing strategies, product redesign priorities, distribution models, and total cost considerations for equipment stakeholders

The cumulative effect of recent tariff actions has injected a new layer of strategic complexity into sourcing, pricing, and supply chain planning for manufacturers and channel partners. Tariff-driven cost pressure has compelled procurement teams to re-evaluate supplier portfolios and accelerated conversations about nearshoring, local assembly, and vertical integration to protect margins and delivery commitments. For equipment vendors dependent on imported components or finished goods, tariffs have increased the urgency of redesigning product bills of materials to favor domestically available alternatives or standardized modules that can be sourced from multiple geographies.

In parallel, tariff policies have influenced route-to-market considerations for distributors and clinics. Some distributors have shifted toward stocking higher levels of finished equipment domestically to buffer customers from lead-time and price volatility, while clinics have become more attuned to total cost of ownership, including replacement parts and consumable pricing. Regulatory compliance and customs classification have taken on greater importance; manufacturers now must invest more in tariff engineering, classification audits, and proactive supplier certifications to secure favorable import treatment where possible. Over the medium term, these dynamics are likely to accelerate product redesigns aimed at component localization, amplify strategic alliances with regional manufacturers, and inspire new commercial models such as equipment-as-a-service to insulate end users from upfront price increases.

Key segmentation insights that interlink product types, power sources, technology modalities, clinical applications, and end-user profiles to reveal strategic market pathways

A refined segmentation lens reveals the breadth of technological, product, and customer dimensions that shape strategy and go-to-market decisions across the sector. Examining product type shows the market spans Acoustic Wave Devices, Cryolipolysis Devices, Laser Based Devices, Radiofrequency Devices, Ultrasound Devices, and Vacuum-Assisted Technology, with laser offerings further divided into Fractional Laser Systems and Non Fractional Laser Systems, and radiofrequency solutions categorized into Bipolar Radiofrequency and Monopolar Radiofrequency. This product diversity creates differentiated clinical value propositions, where applicator design and energy modulation determine both indication breadth and treatment session economics.

Power source segmentation distinguishes between Battery-Powered Devices, Corded Electric Devices, and Rechargeable Wireless Devices, a distinction that affects portability, clinic workflow, and capital allocation decisions. Technology type cuts across clinical modalities and includes Cryolipolysis, Electromagnetic Muscle Stimulation, High-Intensity Focused Ultrasound, Infrared Light Therapy, Laser Lipolysis, Radiofrequency, and Vacuum-Assisted Technology; these technology choices determine treatment portfolios and inform clinician training requirements. Application-based perspectives encompass Cellulite Reduction, Fat Reduction, Full Body Contouring, Muscle Toning, and Skin Tightening, each with distinct patient demand cycles and marketing narratives. Lastly, end-user segmentation into Aesthetic Clinics, Beauty Salons, Hospitals, and Medical Spas highlights the range of operational environments, regulatory exposure, and customer expectations that vendors must navigate when tailoring sales approaches and service models. Integrating these segmentation layers enables a nuanced view of innovation prioritization, pricing strategy, and clinical positioning.

Multidimensional regional insights highlighting how the Americas, Europe Middle East & Africa, and Asia-Pacific each shape adoption patterns, regulation, and commercial models

Regional dynamics continue to exert a strong influence over product adoption patterns, regulatory timelines, and channel structures. In the Americas, demand is shaped by a mixture of consumer-driven aesthetic trends, concentrated clinic networks, and a pragmatic regulatory environment that rewards robust clinical evidence and strong post-market surveillance. Stakeholders in this region often prioritize scalability, ease of use for high-throughput practices, and integrated training programs to accelerate adoption across multi-clinic operators.

In Europe, Middle East & Africa the landscape is heterogeneous; parts of Western Europe emphasize stringent conformity and clinical validation, while other markets within the region demand cost-effective, versatile platforms that can serve mixed-use settings. Regulatory harmonization efforts and regional certification pathways are critical considerations for firms entering multiple jurisdictions. In Asia-Pacific, rapid urbanization and expanding medical tourism create fertile conditions for both premium and mid-tier offerings, with an appetite for feature-rich devices and bundled service models. Across all regions, local reimbursement frameworks, practitioner credentialing norms, and cultural preferences for specific indications will continue to drive differentiated commercial strategies and investment priorities.

Analytical perspective on competitive dynamics, innovation strategies, partnership models, and sources of defensibility that define company performance and resilience

Competitive dynamics in the industry are characterized by a mix of established technology incumbents, agile specialized suppliers, and a growing cohort of venture-backed entrants. Incumbents typically leverage broad distribution networks, established service infrastructures, and deep clinical trial experience to defend share, while smaller innovators compete on targeted clinical advantages, lighter regulatory pathways, and faster iterative development cycles. Partnerships between device makers and clinical research centers are increasingly common as a way to accelerate evidence generation and validate novel indications.

Market participants are also differentiating through aftercare services, consumable ecosystems, and digital treatment adjuncts that lock in recurring revenue streams and improve patient retention. Intellectual property around energy delivery systems, applicator ergonomics, and closed-loop treatment monitoring is a critical source of defensibility. Meanwhile, M&A activity and strategic alliances are reshaping the competitive map as firms seek to broaden portfolios and accelerate access to new channels. For buyers and investors, the most important indicators of resilience are distribution depth, regulatory pathway maturity, and the ability to monetize services beyond the initial equipment sale.

Actionable strategic recommendations for manufacturers, distributors, and clinical operators to strengthen supply resilience, clinical validation, and commercial differentiation

Leaders should adopt a pragmatic, multi-layered strategy to convert market complexity into competitive advantage. Begin by prioritizing supplier diversification and modular product architectures that allow substitution of tariff-sensitive components without compromising clinical performance. This approach reduces exposure to single-source disruptions and shortens the path to localized assembly or contract manufacturing when policy shifts demand it. Simultaneously, invest in rigorous clinical evidence generation that maps device performance to clear patient-reported outcome measures and economic value propositions, as strong data will accelerate adoption and ease regulatory engagement.

Commercially, consider hybrid business models that combine capital sales with service and consumable contracts to stabilize revenue streams and deliver higher lifetime customer value. Expand training and certification programs to reduce practitioner onboarding friction and to create preferred-user networks that increase device utilization. Leverage digital tools for remote monitoring, treatment planning, and outcome tracking, which can differentiate offerings and support premium pricing. Finally, adopt a phased geographic expansion strategy that aligns regulatory readiness with channel development and local partnerships to maximize uptake while containing execution risk.

Transparent mixed-methods research methodology detailing primary and secondary data sources, analytical techniques, validation protocols, and scenario testing employed in the study

This report employs a mixed-methods research approach combining primary interviews, secondary literature review, and triangulated validation to ensure analytical rigor and actionable outputs. Primary research included structured interviews with clinical opinion leaders, procurement specialists, regulatory consultants, and channel partners to capture real-world implementation constraints and evolving demand signals. Secondary sources encompassed peer-reviewed clinical studies, regulatory guidance documents, patent filings, and public company disclosures, which were synthesized to construct technology and competitive narratives.

Analytical methods included qualitative thematic coding of interview data, technology mapping to align modalities with clinical applications, and scenario analysis to evaluate policy and supply chain contingencies. Data integrity was further strengthened through cross-validation of manufacturer claims with independent clinical studies and post-market surveillance reports. Where appropriate, sensitivity checks were applied to qualitative findings to assess robustness across different geographies and end-user contexts. The overall methodology prioritizes transparency and traceability to support confident decision-making by commercial and clinical stakeholders.

Concluding synthesis that distills strategic imperatives, operational trade-offs, and long-term priorities for sustained competitiveness in the evolving body shaping equipment landscape

In conclusion, the non-invasive body shaping equipment market is evolving from modality-centric propositions toward integrated, evidence-driven platforms that emphasize safety, patient experience, and measurable outcomes. Technological progress is enabling broader indications and more efficient clinic workflows, yet supply chain disruptions and policy measures such as tariffs are accelerating strategic shifts in sourcing and product design. Firms that align R&D investments with clear clinical endpoints, diversify supply chains, and build service-centric business models will be best positioned to navigate volatility and capture sustainable growth.

Looking ahead, the interplay between regulatory evolution, regional demand patterns, and technological convergence will determine which companies translate innovation into durable commercial success. Decision-makers should balance near-term operational resilience with long-term investments in clinical evidence and digital capabilities to ensure differentiated offerings and resilient go-to-market execution.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-Invasive Body Shaping Equipment Market, by Product Type

  • 8.1. Acoustic Wave Devices
  • 8.2. Cryolipolysis Devices
  • 8.3. Laser Based Devices
    • 8.3.1. Fractional Laser Systems
    • 8.3.2. Non Fractional Laser Systems
  • 8.4. Radiofrequency Devices
    • 8.4.1. Bipolar Radiofrequency
    • 8.4.2. Monopolar Radiofrequency
  • 8.5. Ultrasound Devices
  • 8.6. Vacuum-Assisted Technology

9. Non-Invasive Body Shaping Equipment Market, by Power Source

  • 9.1. Battery-Powered Devices
  • 9.2. Corded Electric Devices
  • 9.3. Rechargeable Wireless Devices

10. Non-Invasive Body Shaping Equipment Market, by Technology Type

  • 10.1. Cryolipolysis
  • 10.2. Electromagnetic Muscle Stimulation
  • 10.3. High-Intensity Focused Ultrasound
  • 10.4. Infrared Light Therapy
  • 10.5. Laser Lipolysis
  • 10.6. Radiofrequency
  • 10.7. Vacuum-Assisted Technology

11. Non-Invasive Body Shaping Equipment Market, by Application

  • 11.1. Cellulite Reduction
  • 11.2. Fat Reduction
  • 11.3. Full Body Contouring
  • 11.4. Muscle Toning
  • 11.5. Skin Tightening

12. Non-Invasive Body Shaping Equipment Market, by End-User

  • 12.1. Aesthetic Clinics
  • 12.2. Beauty Salons
  • 12.3. Hospitals
  • 12.4. Medical Spas

13. Non-Invasive Body Shaping Equipment Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Non-Invasive Body Shaping Equipment Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Non-Invasive Body Shaping Equipment Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Non-Invasive Body Shaping Equipment Market

17. China Non-Invasive Body Shaping Equipment Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alma Lasers Ltd.
  • 18.6. Asclepion Laser Technologies GmbH
  • 18.7. BioSculpt Solutions, Inc.
  • 18.8. Candela Medical, Inc.
  • 18.9. Croma Aesthetics, Inc.
  • 18.10. CRYO SCIENCE sp.z o.o.
  • 18.11. Cutera, Inc.
  • 18.12. Cynosure, Inc.
  • 18.13. DEKA M.E.L.A. S.r.l. by Elen Group
  • 18.14. Endymed Medical Ltd.
  • 18.15. Erchonia Corporation
  • 18.16. Fotona d.o.o.
  • 18.17. InMode Ltd.
  • 18.18. Konmison
  • 18.19. Lumenis Ltd.
  • 18.20. Lutronic Corporation
  • 18.21. RFHIC Corporation
  • 18.22. Sciton, Inc.
  • 18.23. Silhouette Aesthetics, LLC
  • 18.24. Solta Medical, Inc. by Bausch Health
  • 18.25. Venus Concept, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY ACOUSTIC WAVE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY ACOUSTIC WAVE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY ACOUSTIC WAVE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CRYOLIPOLYSIS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CRYOLIPOLYSIS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CRYOLIPOLYSIS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY FRACTIONAL LASER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY FRACTIONAL LASER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY FRACTIONAL LASER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY NON FRACTIONAL LASER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY NON FRACTIONAL LASER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY NON FRACTIONAL LASER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY BIPOLAR RADIOFREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY BIPOLAR RADIOFREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY BIPOLAR RADIOFREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY MONOPOLAR RADIOFREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY MONOPOLAR RADIOFREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY MONOPOLAR RADIOFREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY VACUUM-ASSISTED TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY VACUUM-ASSISTED TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY VACUUM-ASSISTED TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY BATTERY-POWERED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY BATTERY-POWERED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY BATTERY-POWERED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CORDED ELECTRIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CORDED ELECTRIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CORDED ELECTRIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RECHARGEABLE WIRELESS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RECHARGEABLE WIRELESS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RECHARGEABLE WIRELESS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CRYOLIPOLYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CRYOLIPOLYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY ELECTROMAGNETIC MUSCLE STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY ELECTROMAGNETIC MUSCLE STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY ELECTROMAGNETIC MUSCLE STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY INFRARED LIGHT THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY INFRARED LIGHT THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY INFRARED LIGHT THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER LIPOLYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER LIPOLYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER LIPOLYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY VACUUM-ASSISTED TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY VACUUM-ASSISTED TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY VACUUM-ASSISTED TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CELLULITE REDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CELLULITE REDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY CELLULITE REDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY FAT REDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY FAT REDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY FAT REDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY FULL BODY CONTOURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY FULL BODY CONTOURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY FULL BODY CONTOURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY MUSCLE TONING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY MUSCLE TONING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY MUSCLE TONING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY SKIN TIGHTENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY SKIN TIGHTENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY SKIN TIGHTENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY AESTHETIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY AESTHETIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY AESTHETIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY BEAUTY SALONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY BEAUTY SALONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY BEAUTY SALONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY MEDICAL SPAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY MEDICAL SPAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 170. GCC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GCC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 173. GCC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. GCC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 175. GCC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. GCC NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 194. G7 NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. G7 NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. G7 NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. G7 NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. G7 NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 199. G7 NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. G7 NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 202. NATO NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. NATO NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. NATO NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. NATO NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 207. NATO NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. NATO NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY LASER BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY RADIOFREQUENCY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA NON-INVASIVE BODY SHAPING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)